These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9580191)
41. US resistance to Canadian mammogram study not only about data. Gray C CMAJ; 1993 Feb; 148(4):622-3. PubMed ID: 8431826 [No Abstract] [Full Text] [Related]
42. Big bad pharma: an ethical analysis of physician-directed and consumer-directed marketing tactics. Connors AL Albany Law Rev; 2009 Sep; 73(1):243-82. PubMed ID: 20235401 [No Abstract] [Full Text] [Related]
43. All gifts large and small: toward an understanding of the ethics of pharmaceutical industry gift-giving. Katz D; Caplan AL; Merz JF Am J Bioeth; 2003; 3(3):39-46. PubMed ID: 14594489 [TBL] [Abstract][Full Text] [Related]
44. Pharmacists paid to suggest drugs: some doctors dislike a link with the manufacturers. Kolata G N Y Times Web; 1994 Jul; ():A1, D2. PubMed ID: 11647034 [No Abstract] [Full Text] [Related]
46. Physicians, pharmaceutical representatives, and patients: who really benefits? Westfall JM J Fam Pract; 2000 Sep; 49(9):817-9. PubMed ID: 11032206 [No Abstract] [Full Text] [Related]
47. Ethics in the marketing of medical services. Latham SR Mt Sinai J Med; 2004 Sep; 71(4):243-50. PubMed ID: 15365590 [TBL] [Abstract][Full Text] [Related]
48. Why are many plastic surgeons reluctant to acknowledge and accept the use of marketing in their practices? Grant J; Sykes DG J Hosp Mark; 1991; 6(1):149-53. PubMed ID: 10116631 [No Abstract] [Full Text] [Related]
50. Gather 'round. Weiss R Mark Health Serv; 2013; 33(3):12-3. PubMed ID: 24069681 [No Abstract] [Full Text] [Related]
51. We need dialogue and discussion, not a new Berlin Wall. Erola JA CMAJ; 1994 Mar; 150(6):955-6. PubMed ID: 8131128 [No Abstract] [Full Text] [Related]
52. Marketing health care to the primal brain in the modern world. How neuroscience can improve your marketing. Fredricks D Mark Health Serv; 2012; 32(3):16-9. PubMed ID: 23061254 [No Abstract] [Full Text] [Related]
54. The fine line between education and marketing. Proj Inf Perspect; 1999 Sep; (28):1-3. PubMed ID: 11367352 [TBL] [Abstract][Full Text] [Related]
55. Does pharmaceutical marketing actually have real and proven value? Muller D; Adler L J Gen Intern Med; 1997 Apr; 12(4):258. PubMed ID: 9127234 [No Abstract] [Full Text] [Related]
56. Concern about drug reps. Tsai AC Health Aff (Millwood); 2002; 21(4):296-7; author reply 298-9. PubMed ID: 12117146 [No Abstract] [Full Text] [Related]
57. Word of mouth is the most powerful home care marketing strategy. Ferris MT Caring; 2003 Sep; 22(9):46-7. PubMed ID: 14618905 [No Abstract] [Full Text] [Related]
58. Marketing to the consumer: perspectives from the pharmaceutical industry. David C Mark Health Serv; 2001; 21(1):5-11. PubMed ID: 11291513 [TBL] [Abstract][Full Text] [Related]
59. Drug reps are marketers, period. Williams R Health Aff (Millwood); 2002; 21(4):297-8; author reply 298-9. PubMed ID: 12117147 [No Abstract] [Full Text] [Related]
60. Is the hospital patient market receptive to incentives? Results of an attitude survey. Rothe KW; Turkomani AM J Hosp Mark; 1991; 6(1):53-68. PubMed ID: 10116638 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]